ADC Therapeutics SA shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in ADC Therapeutics SA
Tip: Access up to 7 years of quarterly data
All positions including ADC Therapeutics SA held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in ADC Therapeutics SA by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $263k | 70k | 3.75 |
| 2025-12-31 | $166k | 47k | 3.55 |
| 2025-09-30 | $149k | 37k | 4.00 |
| 2025-06-30 | $100k | 37k | 2.69 |
| 2025-03-31 | $52k | 36k | 1.44 |
| 2024-12-31 | $58k | 29k | 2.01 |
| 2024-09-30 | $91k | 29k | 3.16 |
| 2024-06-30 | $0 | 23k | 0.00 |
| 2023-06-30 | $2.6M | 1.2M | 2.15 |
| 2023-03-31 | $2.5M | 1.3M | 1.95 |
| 2022-12-31 | $5.7M | 1.5M | 3.84 |
| 2022-03-31 | $36M | 2.5M | 14.69 |
| 2021-12-31 | $58M | 2.9M | 20.20 |
| 2021-09-30 | $77M | 2.8M | 27.16 |
| 2021-06-30 | $65M | 2.7M | 24.35 |
| 2021-03-31 | $67M | 2.7M | 24.41 |
| 2020-12-31 | $63M | 2.0M | 32.01 |
| 2020-09-30 | $24M | 719k | 32.99 |
| 2020-06-30 | $28M | 592k | 46.81 |